Article Details
Retrieved on: 2024-04-04 21:19:27
Tags for this article:
Click the tags to see associated articles and topics
Summary
The AACR is bridging academia with biopharma, highlighted by its first "industry partnering" event. Key figures like Michael A. Caligiuri aim to translate scientific discoveries into clinical therapies, with Big Pharma like Pfizer altering strategies amidst legislative changes.
Article found on: www.biospace.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here